FINWIRES · TerminalLIVE
FINWIRES

$LFST

6 stories mentioning LFSTUpdated 13d ago

Every FINWIRES story that references LFST, newest first.

What's the latest news on LFST?

Wire

Update: LifeStance Launches Secondary Offering, Concurrent Share Repurchase

(Updates with more information in the first two paragraphs and stock move in the last paragraph.)LifeStance Health Group (LFST) said Wednesday that certain stockholders plan to offer roughly 22.3 million common shares for $12.35 apiece under a shelf registration.The company said it will not receive any proceeds from the offering, which is expected to close around Friday.Additionally, LifeStance said it has authorized the concurrent purchase of 2 million shares from the underwriter at the same price paid to selling stockholders, subject to completion of the offering.Shares of the company were down 2.5% in Wednesday trading.Price: $12.49, Change: $-0.32, Percent Change: -2.46%

$LFST
Insider Trading

Lifestance Health Group Insider Sold Shares Worth $541,402, According to a Recent SEC Filing

Vukasin Paunovich, Chief Technology Officer, on September 02, 2026, sold 42,067 shares in Lifestance Health Group (LFST) for $541,402. Following the Form 4 filing with the SEC, Paunovich has control over a total of 205,379 common shares of the company, with 205,379 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526383783/xslF345X05/ownership.xml

$LFST
Insider Trading

Lifestance Health Group Insider Sold Shares Worth $5,755,000, According to a Recent SEC Filing

Kenneth A Burdick, Director, on August 11, 2026, sold 500,000 shares in Lifestance Health Group (LFST) for $5,755,000. Following the Form 4 filing with the SEC, Burdick has control over a total of 3,017,321 common shares of the company, with 2,970,810 shares held directly and 46,511 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526349559/xslF345X05/ownership.xml

$LFST
Insider Trading

Lifestance Health Group Insider Sold Shares Worth $481,675, According to a Recent SEC Filing

Vukasin Paunovich, Chief Technology Officer, on August 10, 2026, sold 44,394 shares in Lifestance Health Group (LFST) for $481,675. Following the Form 4 filing with the SEC, Paunovich has control over a total of 247,446 common shares of the company, with 247,446 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526347131/xslF345X05/ownership.xml

$LFST
Sectors

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

Health care stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) retreating by 0.1% and the iShares Biotechnology ETF (IBB) advancing 0.1%.Cytokinetics (CYTK) shares fell more than 1% premarket after the company said late Wednesday it priced its upsized public offering of about 9.9 million shares at $71 a piece for gross proceeds of around $700 million.Catalyst Pharmaceuticals (CPRX) stock was gaining over 2% before the opening bell after the company agreed to be acquired by Angelini Pharma in a deal with an equity value of about $4.1 billion. The company also said it has reached a settlement agreement with Hetero Labs to resolve patent litigation regarding a proposed generic version of Firdapse, or amifampridine.Lifestance Health Group (LFST) shares rose 11% after the company reported higher Q1 earnings and revenue.

$CPRX$CYTK$IBB$LFST$XLV
Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST

Track with the FINWIRES app suite